Jensen Victoria Svop, Hvid Henning, Damgaard Jesper, Nygaard Helle, Ingvorsen Camilla, Wulff Erik Max, Lykkesfeldt Jens, Fledelius Christian
1Department of Veterinary and Animal Science, Faculty of Health and Medical Sciences, University of Copenhagen, Ridebanevej 9, 1870 Frederiksberg, Denmark.
2Insulin Pharmacology, Novo Nordisk A/S, Novo Nordisk Park 1, 2760 Maaloev, Denmark.
Diabetol Metab Syndr. 2018 Jan 24;10:4. doi: 10.1186/s13098-018-0307-8. eCollection 2018.
In humans and animal models, excessive intake of dietary fat, fructose and cholesterol has been linked to the development of non-alcoholic fatty liver disease (NAFLD). However, the individual roles of the dietary components remain unclear. To investigate this further, we compared the effects of a high-fat diet, a high-fructose diet and a combination diet with added cholesterol on the development of NAFLD in rats.
Forty male Sprague-Dawley rats were randomized into four groups receiving either a control-diet (Control: 10% fat); a high-fat diet (HFD: 60% fat, 20% carbohydrate), a high-fructose diet [HFr: 10% fat, 70% carbohydrate (mainly fructose)] or a high-fat/high-fructose/high-cholesterol-diet (NASH: 40% fat, 40% carbohydrate (mainly fructose), 2% cholesterol) for 16 weeks.
After 16 weeks, liver histology revealed extensive steatosis and inflammation in both NASH- and HFD-fed rats, while hepatic changes in HFr-rats were much more subtle. These findings were corroborated by significantly elevated hepatic triglyceride content in both NASH- ( < 0.01) and HFD-fed rats ( < 0.0001), elevated hepatic cholesterol levels in NASH-fed rats ( < 0.0001), but no changes in HFr-fed rats, compared to Control. On the contrary, only HFr-fed rats developed dyslipidemia as characterized by higher levels of plasma triglycerides compared to all other groups ( < 0.0001). Hepatic dysfunction and inflammation was confirmed in HFD-fed rats by elevated levels of hepatic MCP-1 ( < 0.0001), TNF-alpha ( < 0.001) and plasma β-hydroxybutyrate ( < 0.0001), and in NASH-fed rats by elevated levels of hepatic MCP-1 ( < 0.01), increased hepatic macrophage infiltration ( < 0.001), and higher plasma levels of alanine aminotransferase ( < 0.0001) aspartate aminotransferase ( < 0.05), haptoglobin ( < 0.001) and TIMP-1 ( < 0.01) compared to Control.
These findings show that dietary fat and cholesterol are the primary drivers of NAFLD development and progression in rats, while fructose mostly exerts its effect on the circulating lipid pool.
在人类和动物模型中,过量摄入膳食脂肪、果糖和胆固醇与非酒精性脂肪性肝病(NAFLD)的发生有关。然而,这些膳食成分各自的作用仍不明确。为了进一步研究这一问题,我们比较了高脂饮食、高果糖饮食以及添加胆固醇的联合饮食对大鼠非酒精性脂肪性肝病发生发展的影响。
将40只雄性斯普拉格-道利大鼠随机分为四组,分别给予对照饮食(对照组:10%脂肪)、高脂饮食(HFD:60%脂肪,20%碳水化合物)、高果糖饮食[HFr:10%脂肪,70%碳水化合物(主要为果糖)]或高脂/高果糖/高胆固醇饮食(NASH:40%脂肪,40%碳水化合物(主要为果糖),2%胆固醇),持续16周。
16周后,肝脏组织学检查显示,NASH组和HFD组大鼠均出现广泛的脂肪变性和炎症,而HFr组大鼠的肝脏变化则较为轻微。与对照组相比,NASH组(<0.01)和HFD组大鼠(<0.0001)肝脏甘油三酯含量显著升高,NASH组大鼠肝脏胆固醇水平升高(<0.0001),而HFr组大鼠无变化,这些结果证实了上述组织学发现。相反,只有HFr组大鼠出现血脂异常,其血浆甘油三酯水平高于所有其他组(<0.0001)。HFD组大鼠肝脏MCP-1水平升高(<0.0001)、TNF-α水平升高(<0.001)以及血浆β-羟基丁酸水平升高(<0.0001),证实了肝脏功能障碍和炎症;与对照组相比,NASH组大鼠肝脏MCP-1水平升高(<0.01)、肝脏巨噬细胞浸润增加(<0.001),血浆丙氨酸氨基转移酶水平升高(<0.0001)、天冬氨酸氨基转移酶水平升高(<0.05)、触珠蛋白水平升高(<0.001)以及TIMP-1水平升高(<0.01),也证实了肝脏功能障碍和炎症。
这些发现表明,膳食脂肪和胆固醇是大鼠非酒精性脂肪性肝病发生发展的主要驱动因素,而果糖主要对循环脂质池产生影响。